spacer
home > pmps > spring 2018 > the deal structure
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Deal Structure

Licence or acquisition? That is the question. Being an entrepreneur whose technology is sought after by other companies is a great position to be in, but the decisions moving forward can greatly affect your success and the outcome of your project. Pros and cons exist to both ways of going, and I will lay the key points to think about if you are fortunate enough to be in this position.

A licence agreement grants a third party the right to manufacture and/or market an invention/technology for a specific territory, ie globally or just in the US, Europe, or Asia. The company receives a royalty, an advance against future royalties, and often milestone payments.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Quanticate Partners with CluePoints to Offer Data Quality Oversight capabilities

Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints as part of its new Data Quality Oversight service.
More info >>

White Papers

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

Phlexglobal Ltd

Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >>

 
Industry Events

Partnerships in Clinical Trials Europe 2018

27-29 November 2018, CCIB, Barcelona

Partnerships in Clinical Trials Europe is back – and bigger than ever. Europe’s most complete clinical meeting is bringing together 1000+ of the industry’s leading experts this November for it’s 17th annual gathering, and you’re invited!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement